Discover 1,298 paid clinical trials in Mesa, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,298
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Phoenix AZ, Loma Linda CA, Downey CA, Los Angeles CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase 3, Recruiting
Active & Responsive
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
for
Acute Myeloid Leukemia
Location: Phoenix AZ, Duarte CA, Salt Lake City UT, Stanford CA,
Sponsor: Norman J. Lacayo
Sex: All
Age: 0 - 21
Code: NCT05101551
Phase 1, Recruiting
Active & Responsive
Danon Disease Natural History Study
for
Danon Disease
Location: Phoenix AZ, La Jolla CA, Aurora CO, Dallas TX,
Sponsor: Rocket Pharmaceuticals Inc.
Sex: All
Age: 8+
Code: NCT06214507
Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Phoenix AZ, Los Angeles CA, Aurora CO, Palo Alto CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase 2, Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: Phoenix AZ, Las Vegas NV, San Diego CA, El Paso TX,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Location: Phoenix AZ, Albuquerque NM, Salt Lake City UT,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06526195
Recruiting
Active & Responsive
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
for
Focal Onset Seizures
Location: Phoenix AZ, Tucson AZ, El Paso TX, Orange CA,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT06798896
Phase 2, Recruiting
Active & Responsive
VEDA Study (DHEA vs Estradiol)
for
Post-menopause, Pre-menopause, Sexual Function, Menopause,
Location: Phoenix AZ
Sponsor: University of Arizona
Sex: Female
Age: 40 - 70+
Code: NCT07574216
Recruiting
Active & Responsive
A Post-Market Assessment of the Safety and Performance of the TriClip™ System
for
Tricuspid Regurgitation (TR)
Location: Phoenix AZ, La Jolla CA, Austin TX, Chicago IL,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT07586995
Recruiting
Active & Responsive
AMEND TS Early Feasibility Study
for
Symptomatic Functional MR 3 or Greater
Location: Phoenix AZ, San Antonio TX, Houston TX, Portland OR,
Sponsor: Valcare Medical Ltd.
Sex: All
Age: 21+
Code: NCT06951672
Recruiting
Active & Responsive
Examination of Nociscan Impact on Low Back Pain Surgical Outcomes
for
Low Back Pain
Location: Phoenix AZ, La Jolla CA, Los Angeles CA,
Sponsor: Aclarion
Sex: All
Age: 18 - 70
Code: NCT06661850
Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Location: Phoenix AZ, Las Vegas NV, Spring Valley CA,
Sponsor: Amgen
Sex: All
Age: 45 - 70+
Code: NCT07037433
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer